Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | seekingalpha.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | news.google.com • |
NASDAQ: OCGN Investor Notice: Update in Lawsuit for Investors Who Lost Money With Ocugen, Inc. Shares Announced by the Shareholders Foundation | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.06 | -0.04 | 0.02 | 33.33% |
2024-05-14 | 2024-03 | -0.06 | -0.05 | 0.01 | 16.67% |
2024-04-16 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-09 | 2023-09 | -0.08 | -0.06 | 0.02 | 25.00% |
2023-08-21 | 2023-06 | -0.08 | -0.1 | -0.02 | -25.00% |
2023-05-05 | 2023-03 | -0.11 | -0.07 | 0.04 | 36.36% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-22 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-07 | Chardan Capital | Upgrade | Buy | |
2023-04-16 | HC Wainwright & Co. | Upgrade | Buy | |
2023-04-13 | Chardan Capital | Upgrade | Buy | |
2023-02-28 | Chardan Capital | Upgrade | Neutral | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-10 | CASTILLO KIRSTEN M | Director | 50.00K | Sale |
2023-01-02 | CRESPO JESSICA | Officer | 163.39K | Stock Award(Grant) |
2021-05-24 | FERNANDES PRABHAVATHI | Director | 0.00 | Sale |
2021-11-01 | KOMPELLA UDAY B. | Director | 0.00 | Sale |
2022-10-05 | KUMAR RAMESH | Director | 0.00 | Sale |
2023-02-15 | MUSUNURI SHANKAR PH.D | Chief Executive Officer | 3.34M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 11.81M | 6.41M | 4.60% |
2023-06-29 | Luminus Management, LLC | 4.08M | 2.22M | 1.59% |
2023-06-29 | GMT Capital Corp | 3.92M | 2.13M | 1.53% |
2023-06-29 | Blackrock Inc. | 3.91M | 2.12M | 1.52% |
2023-06-29 | JP Morgan Chase & Company | 3.04M | 1.65M | 1.19% |
2023-06-29 | Millennium Management Llc | 3.02M | 1.64M | 1.18% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 7.60M | 4.13M | 2.96% |
2023-06-29 | Vanguard Extended Market Index Fund | 3.06M | 1.66M | 1.19% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.07M | 490.29K | 0.42% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 921.56K | 423.92K | 0.36% |
2023-05-30 | Vanguard Health Care Index Fund | 738.21K | 339.58K | 0.29% |
2023-05-30 | Vanguard Russell 2000 Index Fund | 597.25K | 274.74K | 0.23% |
Split | Date |
---|---|
1 : 60 | 2019-09-30 |
-
This stock has nothing to do with sales in India
-
Guys.
Look at the now
Since we got some light they start put scary stuff here about OCGN.That’s great. When bears start shacking I feel like the sun will come out!!!!!
Let’s go OCGN !!!!
We are bulls. !!!
-
$OCGN Yall gotta relax, this thing is at the end of development which means it gonna start moving soon. I figure, best case without PR give it a week or two, worst case, you sit on your INVESTMENT and let it run a few months maybe to Q3 and so much will have been done that you are sitting in a pile of cash. I’m down right now, like many of you. But I know this thing can BOOM any day or sometime this year. Warren Buffet didn’t get rich day trading. He actually said people don’t make it in the stock market because it’s a “GET RICH SLOW” game. Patients will get you where you want to be. I’ve personally used Ocugen products and they are solid. They are making big moves right now, buy in and let the show begin.
-
-
This is a slow mover but big blast is coming soon as India vaccination already started and FDA approval is in progress
-
-
-
$OCGN it will pop up on news!
-
-
-
We end green today. IMO.
🧩🧑🧤🩲🪖🦖🦚️🥦🥬🫑🪀🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠🦠 -
-
-
-
Patient
Logic
Risk assessment
VisionThis is why I’m staying with OCGN.
It will come! IMO.
-
Guys I’m sorry but I will ask again
Why CEO did not provide the mutation data he promise ????“ give me a week “ he said. No?
Can some one answers me ?
Tyvm guys wishing you all great day !!! -
-
Guys. Good morning.
Why we do not have the mutation resistance result so far???
Isn’t CEO promise it until this morning ( India time ) ?????
🤨🤨🤨🤨🤨 -
With India vaccination starting this week, FDA approval will come soon and this stock will fly to $5+
-
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
seekingalpha.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
news.google.com • -
Ocugen Inc. stock rises Friday, outperforms market
news.google.com • -
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
globenewswire.com • -
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com • -
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years
investorplace.com • -
Ocugen: Paradigm Shift Gene Therapy Facing Cash Flow Hurdles
seekingalpha.com •